GLG News by Neonatal-Perinatal Physicians

The well-regarded Multimodal Treatment study (MTA Study) has shown that adjunctive, behavioral treatment alone is not as effective as treatment options which include medications. Parent input (and education), however, is critical for day-to-day management of these children, since the parents are on...

As physicians, we should have nothing to hide when we provide unbiased advice to pharmaceutical companies. Receiving a grant (or a lunch or a free pen) does not, for the vast majority, obligate us to be anything other than concerned for our patients, first and foremost.

Psychotherapy saves money in the long-run.  Even though, the direct costs of psychotherapy are an added expense, it saves many indirect expenses.

Many drugs for children are being used off-label, since they haven't been studied in children.  It would be nice to have registration trials for these drugs in kids, so that they have official approval of the regulatory bodies. 

Monoclonal antibodies are the drugs of the future.  They will grow at impressive rates are have much less competition than other drugs.

In this small and short-duration study, ACE inhibitors seem to provide an additional preventive benefit when used with beta blockers in patients with marfan's syndrome. This is all to the good for those patients, and if the results of this preliminary study are borne out over a longer term, this may...

Children have long been therapeutic orphans, often relying on off-label use of new drugs which have only been tested on adults. This legislation seeks to remedy that inequality, by encouraging pharmaceutical companies to do more testing in pediatric populations.

With Abbott being such a major player in the infant formula market, will this lead to more promotion of statins in the pediatric office, especially given the recent (although controversial) recommendation for possible statin use in children as young as 8 years old? And since they are involved in the...

Cervical cancer is real, and has the potential to cause significant morbidity and mortality. Yet the incidence in developed countries is relatively small, when compared with the developing world. There is a real, although small, benefit in the US, and while the vaccine is effective, the cost per prevented...

Finally, a recommendation that an available test and treatment NOT be used, under circumstances where there is little to be gained and much to be lost.